1. Hoover R, Fraumeni Jr JF . Risk of cancer in renal-transplant patients. Lancet 1973; 2: 55–57.
2. Harris NL, Swerdlow SH, Frizzera G, Knowles DM . Post-transplant lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2001.
3. Leblond V, Sutton L, Dorent R, Davi F, Bitker MO, Gabarre J et al. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single centre. J Clin Oncol 1995; 13: 961–968.
4. Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 1991; 10: 877–886.
5. Nalesnik MA, Makowka L, Starzl TE . The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 1988; 25: 365–472.